Quanterix Corporation (NASDAQ:QTRX) Given Average Recommendation of “Hold” by Analysts

Quanterix Corporation (NASDAQ:QTRX) has been given an average rating of “Hold” by the five analysts that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $11.3333.

Several equities research analysts have issued reports on QTRX shares. Canaccord Genuity Group lifted their target price on shares of Quanterix from $5.00 to $8.00 and gave the company a “hold” rating in a research report on Monday, December 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of Quanterix in a research report on Wednesday, October 8th. Finally, Wall Street Zen raised shares of Quanterix from a “sell” rating to a “hold” rating in a report on Monday, December 29th.

Hedge Funds Weigh In On Quanterix

Institutional investors have recently modified their holdings of the company. Intech Investment Management LLC raised its holdings in shares of Quanterix by 13.4% during the 3rd quarter. Intech Investment Management LLC now owns 19,161 shares of the company’s stock valued at $104,000 after buying an additional 2,268 shares in the last quarter. Jane Street Group LLC boosted its stake in Quanterix by 4.2% in the first quarter. Jane Street Group LLC now owns 58,313 shares of the company’s stock worth $380,000 after buying an additional 2,366 shares in the last quarter. Rhumbline Advisers grew its position in Quanterix by 7.2% during the second quarter. Rhumbline Advisers now owns 60,629 shares of the company’s stock valued at $403,000 after acquiring an additional 4,094 shares during the last quarter. Vanguard Personalized Indexing Management LLC raised its stake in shares of Quanterix by 40.5% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 15,024 shares of the company’s stock worth $100,000 after acquiring an additional 4,330 shares in the last quarter. Finally, Quarry LP lifted its holdings in shares of Quanterix by 277,300.0% in the 3rd quarter. Quarry LP now owns 5,548 shares of the company’s stock worth $30,000 after acquiring an additional 5,546 shares during the last quarter. 86.48% of the stock is currently owned by institutional investors.

Quanterix Price Performance

Shares of NASDAQ QTRX opened at $6.43 on Tuesday. The stock’s 50-day simple moving average is $6.40 and its two-hundred day simple moving average is $5.82. Quanterix has a twelve month low of $4.05 and a twelve month high of $12.41. The firm has a market capitalization of $300.35 million, a P/E ratio of -2.76 and a beta of 1.00.

Quanterix (NASDAQ:QTRX) last issued its quarterly earnings results on Monday, November 10th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.13). Quanterix had a negative net margin of 73.47% and a negative return on equity of 21.34%. The business had revenue of $40.23 million for the quarter, compared to the consensus estimate of $37.85 million. As a group, research analysts anticipate that Quanterix will post -0.98 EPS for the current fiscal year.

Quanterix Company Profile

Quanterix Corporation is a life sciences and diagnostics company specializing in ultra-sensitive digital immunoassay platforms. Its proprietary Single Molecule Array (Simoa) technology enables researchers to detect and quantify proteins, peptides and nucleic acids at femtomolar concentrations, offering sensitivity that surpasses traditional immunoassay methods. By translating single-molecule detection into routine laboratory workflows, Quanterix aims to accelerate biomarker discovery and the development of novel diagnostics and therapeutics.

The company’s core product portfolio includes the Simoa HD-1 and HD-X Analyzers, which automate high-throughput digital immunoassays for quantifying low-abundance biomarkers.